Nautilus Biotechnology, Inc.
NAUT
$0.758
$0.03474.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.26% | 11.73% | 16.11% | 13.56% | 11.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.99% | 12.48% | 17.73% | 21.39% | 19.70% |
| Operating Income | -6.99% | -12.48% | -17.73% | -21.39% | -19.70% |
| Income Before Tax | -11.16% | -16.90% | -19.57% | -18.05% | -9.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.16% | -16.90% | -19.57% | -18.05% | -9.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.16% | -16.90% | -19.57% | -18.05% | -9.93% |
| EBIT | -6.99% | -12.48% | -17.73% | -21.39% | -19.70% |
| EBITDA | -7.00% | -12.12% | -17.28% | -20.80% | -19.07% |
| EPS Basic | -10.60% | -16.42% | -19.13% | -17.78% | -9.74% |
| Normalized Basic EPS | -10.33% | -19.06% | -21.79% | -20.52% | -12.61% |
| EPS Diluted | -10.60% | -16.42% | -19.13% | -17.78% | -9.74% |
| Normalized Diluted EPS | -10.33% | -19.06% | -21.79% | -20.52% | -12.61% |
| Average Basic Shares Outstanding | 0.52% | 0.40% | 0.35% | 0.23% | 0.15% |
| Average Diluted Shares Outstanding | 0.52% | 0.40% | 0.35% | 0.23% | 0.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |